The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Poulvac Bursine 2 lyophilisate for suspension for spray vaccination or for use in drinking water for chickens

tissue culture infective dose 50/dose Lyophilisate for suspension

Zoetis Belgium S.A.VPA10387/091/001

Main Information

Trade NamePoulvac Bursine 2 lyophilisate for suspension for spray vaccination or for use in drinking water for chickens
Active SubstancesInfectious bursal disease virus strain lukert
Strength tissue culture infective dose 50/dose
Dosage FormLyophilisate for suspension
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/091/001

Group Information

ATC CodeQI01AD09 avian infectious bursal disease virus (gumboro disease)
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

Authorised/WithdrawnAuthorised
Licence Issued18/09/2015
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back